bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

hooksAmpRedirectArticle

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

paywallTypes

createdDate

publishedDate

sponsorType

urlAlias

moreOnThisArticles

commentCount

authorLocations

authors

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

articleSpeeches

socialHeadline

headline

images

flag

firstTopic

glossary

flattenTypeIds

image

relatedLinks

relatedNewsletters

__typename

sponsor

pdfFiles

seriesReverseOrder

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

readingTime

customTimezone

liveContents

The US Centers for Disease Control and Prevention (CDC) said on Thursday it was monitoring a new strain of bird flu and has started work on a vaccine just in case it is needed.
So far, the strain known as avian influenza A (H7N9) has only been found in China and does not appear to be capable of being passed from person to person.
 

	View H7N9 map in a larger map
The strain has killed five people, and global health officials are discussing if and when it may be necessary to start producing a vaccine.
The infections in China mark the first time humans have been afflicted by this new strain of bird flu, which causes severe respiratory illness.
CDC spokesman Tom Skinner said the agency is monitoring the situation closely and working with its domestic and international partners.
The CDC has begun reviewing genetic sequence information on the strain and started the process of making a “seed” virus, a genetically modified version of the virus that could be used by manufacturers to make a vaccine. Because the agency is using artificial or synthetic DNA for this step, Skinner said the seed virus may be available within the next few weeks.
Then, several weeks of testing the seed virus in ferrets would be required to determine if it can be used to make a vaccine. If the answer is yes, then ramping up production would take several months. All told, said Skinner, production of a vaccine against the new strain - should one be needed - would not be underway for five to six months.
Before full-scale production of a vaccine begins, however, there are several questions that must be addressed, especially whether the virus is being transmitted from person to person.
“Right now there is no evidence to suggest that is the case,” Skinner said in a telephone interview.
CDC labs will also be conducting tests to see if the virus is susceptible to current antiviral drugs used to treat flu, such as Roche Holding AG’s Tamiflu, he said.
However, Skinner stressed that the steps the CDC is taking are routine preparedness measures that often apply when a new flu virus is detected in people.
Most conventional flu vaccines in the United States are still made using a 60-year-old process in which the vaccine is grown in fertilised chicken eggs. That method can take several months to complete, but it is changing.
In November, Novartis won US regulatory approval to sell its cell-based flu vaccine, which uses a speedier manufacturing process.
In January, privately held Protein Sciences Corp won US approval to develop the first gene-based flu vaccine, which uses genetic engineering to grow portions of the virus in insect cells rather than eggs.
Other US flu vaccine makers include Sanofi SA, AstraZeneca Plc and GlaxoSmithKline.
 


Bird flu spread in China closely linked to poultry trade, study says

Hong Kong to remain vigilant over bird flu threat, health chief Sophia Chan vows, as Japanese research confirms H7N9 virus can be transmitted via respiratory droplets

Simulated global pandemic leaves 150 million dead. A real one could be much worse

Virus test developed by 15 Hong Kong university students could mean difference between life and death in an epidemic

H7N9 virus

US says preparing vaccine for new bird flu strain

A doctor in a hospital where a patient with H7N9 bird flu strain is being treated in Hangzhou, China. In the US, doctors have started work on a vaccine. Photo: Reuters

News

World